Nephro-Urology Monthly

Published by: Kowsar

Splenic Marginal Zone Lymphoma and Concurrent Membranoproliferative Glomerulonephritis With IgMKappa Deposits in a HCV-Seropositive Patient

Eleni Chelioti 1 , * , Evdokia Efthimiou 1 , Maria Sotiraki 1 , Alexia Papalexandrou 1 and Maria Tsilivigkou 1
Authors Information
1 Department of Nephrology, General Hospital of Piraeus, Athens, Greece
Article information
  • Nephro-Urology Monthly: July 01, 2014, 6 (4); e18391
  • Published Online: July 5, 2014
  • Article Type: Case Report
  • Received: February 21, 2014
  • Revised: March 19, 2014
  • Accepted: March 26, 2014
  • DOI: 10.5812/numonthly.18391

To Cite: Chelioti E, Efthimiou E, Sotiraki M, Papalexandrou A, Tsilivigkou M. Splenic Marginal Zone Lymphoma and Concurrent Membranoproliferative Glomerulonephritis With IgMKappa Deposits in a HCV-Seropositive Patient, Nephro-Urol Mon. 2014 ; 6(4):e18391. doi: 10.5812/numonthly.18391.

Copyright © 2014, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011; 31(4): 341-8[DOI][PubMed]
  • 2. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis--a new look at an old entity. N Engl J Med. 2012; 366(12): 1119-31[DOI][PubMed]
  • 3. Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford). 2007; 46(8): 1234-42[DOI][PubMed]
  • 4. Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002; 347(2): 89-94[DOI][PubMed]
  • 5. Isaacson PG, Matutes E, Burke M, Catovsky D. The histopathology of splenic lymphoma with villous lymphocytes. Blood. 1994; 84(11): 3828-34[PubMed]
  • 6. Matutes E, Morilla R, Owusu-Ankomah K, Houlihan A, Catovsky D. The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood. 1994; 83(6): 1558-62[PubMed]
  • 7. Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematol. 2003; 120(5): 759-64[PubMed]
  • 8. Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013; 119(3): 629-38[DOI][PubMed]
  • 9. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006; 107(12): 4643-9[DOI][PubMed]
  • 10. Kowalewska J, Nicosia RF, Smith KD, Kats A, Alpers CE. Patterns of glomerular injury in kidneys infiltrated by lymphoplasmacytic neoplasms. Hum Pathol. 2011; 42(6): 896-903[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments